Issue navigation
Volume 13, Issue 5, October 2020
Editorial Comments
Ckj consolidation among Q1 Urology and Nephrology journals
Clinical Kidney Journal, Volume 13, Issue 5, October 2020, Pages 723–727, https://doi.org/10.1093/ckj/sfaa197
SGLT2 inhibitors for non-diabetic kidney disease: drugs to treat CKD that also improve glycaemia
Clinical Kidney Journal, Volume 13, Issue 5, October 2020, Pages 728–733, https://doi.org/10.1093/ckj/sfaa198
Complement and protection from tissue injury in COVID-19
Clinical Kidney Journal, Volume 13, Issue 5, October 2020, Pages 734–738, https://doi.org/10.1093/ckj/sfaa196
Eculizumab, SARS-CoV-2 and atypical hemolytic uremic syndrome
Clinical Kidney Journal, Volume 13, Issue 5, October 2020, Pages 739–741, https://doi.org/10.1093/ckj/sfaa166
Advocacy for renal replacement therapy: the role of renal registries
Clinical Kidney Journal, Volume 13, Issue 5, October 2020, Pages 742–744, https://doi.org/10.1093/ckj/sfaa067
Prediction scores for risk of allograft loss in patients receiving kidney transplants: nil satis nisi optimum
Clinical Kidney Journal, Volume 13, Issue 5, October 2020, Pages 745–748, https://doi.org/10.1093/ckj/sfaa081
Longer or shorter dual antiplatelet therapy in dialysis patients receiving a coronary drug-eluting stent? A rope game still ongoing
Clinical Kidney Journal, Volume 13, Issue 5, October 2020, Pages 749–752, https://doi.org/10.1093/ckj/sfaa040
Pelacarsen for lowering lipoprotein(a): implications for patients with chronic kidney disease
Clinical Kidney Journal, Volume 13, Issue 5, October 2020, Pages 753–757, https://doi.org/10.1093/ckj/sfaa001
CKJ Reviews
Recurrence of immunoglobulin A nephropathy after kidney transplantation: a narrative review of the incidence, risk factors, pathophysiology and management of immunosuppressive therapy
Clinical Kidney Journal, Volume 13, Issue 5, October 2020, Pages 758–767, https://doi.org/10.1093/ckj/sfaa060
The genetic map of diabetic nephropathy: evidence from a systematic review and meta-analysis of genetic association studies
Clinical Kidney Journal, Volume 13, Issue 5, October 2020, Pages 768–781, https://doi.org/10.1093/ckj/sfaa077
Original Articles
Survival of South African patients on renal replacement therapy
Clinical Kidney Journal, Volume 13, Issue 5, October 2020, Pages 782–790, https://doi.org/10.1093/ckj/sfaa012
Prognostic value for long-term graft survival of estimated glomerular filtration rate and proteinuria quantified at 3 months after kidney transplantation
Clinical Kidney Journal, Volume 13, Issue 5, October 2020, Pages 791–802, https://doi.org/10.1093/ckj/sfaa044
Clinical outcomes of prolonged dual antiplatelet therapy after coronary drug-eluting stent implantation in dialysis patients
Clinical Kidney Journal, Volume 13, Issue 5, October 2020, Pages 803–812, https://doi.org/10.1093/ckj/sfaa037
Musculoskeletal pain reported by mobile patients with chronic kidney disease
Clinical Kidney Journal, Volume 13, Issue 5, October 2020, Pages 813–820, https://doi.org/10.1093/ckj/sfz196
Contemporary management of anaemia, erythropoietin resistance and cardiovascular risk in patients with advanced chronic kidney disease: a nationwide analysis
Clinical Kidney Journal, Volume 13, Issue 5, October 2020, Pages 821–827, https://doi.org/10.1093/ckj/sfaa054
Measurement of glomerular filtration rate in lung transplant recipients highlights a dramatic loss of renal function after transplantation
Clinical Kidney Journal, Volume 13, Issue 5, October 2020, Pages 828–833, https://doi.org/10.1093/ckj/sfaa053
A clinical predictive model of renal injury in children with isolated antenatal hydronephrosis
Clinical Kidney Journal, Volume 13, Issue 5, October 2020, Pages 834–841, https://doi.org/10.1093/ckj/sfz102
Association of non-invasive measures of subclinical atherosclerosis and arterial stiffness with mortality and major cardiovascular events in chronic kidney disease: systematic review and meta-analysis of cohort studies
Clinical Kidney Journal, Volume 13, Issue 5, October 2020, Pages 842–854, https://doi.org/10.1093/ckj/sfz095
Advanced glycation endproducts and dicarbonyls in end-stage renal disease: associations with uraemia and courses following renal replacement therapy
Clinical Kidney Journal, Volume 13, Issue 5, October 2020, Pages 855–866, https://doi.org/10.1093/ckj/sfz099
Home run—results of a chronic kidney disease Telemedicine Patient Education Study
Clinical Kidney Journal, Volume 13, Issue 5, October 2020, Pages 867–872, https://doi.org/10.1093/ckj/sfz096
Regulation of urinary calcium excretion by vasopressin
Clinical Kidney Journal, Volume 13, Issue 5, October 2020, Pages 873–877, https://doi.org/10.1093/ckj/sfaa134
Risk factors for severity of COVID-19 in chronic dialysis patients from a multicentre French cohort
Clinical Kidney Journal, Volume 13, Issue 5, October 2020, Pages 878–888, https://doi.org/10.1093/ckj/sfaa199
Temporal changes in complement activation in haemodialysis patients with COVID-19 as a predictor of disease progression
Clinical Kidney Journal, Volume 13, Issue 5, October 2020, Pages 889–896, https://doi.org/10.1093/ckj/sfaa192
Exceptional Case
A loosening prosthesis in a dialysis patient
Clinical Kidney Journal, Volume 13, Issue 5, October 2020, Pages 897–899, https://doi.org/10.1093/ckj/sfz078
Letters to the Editor
Home dialysis machine use for emergency dialysis during the COVID-19 pandemic
Clinical Kidney Journal, Volume 13, Issue 5, October 2020, Pages 900–902, https://doi.org/10.1093/ckj/sfaa186
Cilastatin: a potential treatment strategy against COVID-19 that may decrease viral replication and protect from the cytokine storm
Clinical Kidney Journal, Volume 13, Issue 5, October 2020, Pages 903–905, https://doi.org/10.1093/ckj/sfaa193
Discrepancies between bioimpedance spectroscopy devices in haemodialysis patients
Clinical Kidney Journal, Volume 13, Issue 5, October 2020, Pages 906–908, https://doi.org/10.1093/ckj/sfz147
Errata
New insights from the application of the FAbry STabilization indEX in a large population of Fabry cases
Clinical Kidney Journal, Volume 13, Issue 5, October 2020, Page 909, https://doi.org/10.1093/ckj/sfz010
Impact of errors of creatinine and cystatin C equations in the selection of living kidney donors
Clinical Kidney Journal, Volume 13, Issue 5, October 2020, Page 910, https://doi.org/10.1093/ckj/sfz052
Frailty is independently associated with worse health-related quality of life in chronic kidney disease: a secondary analysis of the Frailty Assessment in Chronic Kidney Disease study
Clinical Kidney Journal, Volume 13, Issue 5, October 2020, Page 911, https://doi.org/10.1093/ckj/sfz079
